Living donor kidney transplantation in patients with hereditary nephropathies (Q33392071)

26 July 2017

title

Living donor kidney transplantation in patients with hereditary nephropathies (English)

1 reference

26 July 2017

main subject

kidney transplantation

1 reference

1

Patrick Niaudet

1 reference

26 July 2017

language of work or name

English

0 references

publication date

28 September 2010

1 reference

Nature Reviews Nephrology

26 July 2017

published in

1 reference

26 July 2017

volume

6

1 reference

26 July 2017

issue

12

1 reference

26 July 2017

page(s)

736-743

1 reference

Recurrent diseases in the kidney transplant

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Living-donor kidney transplantation: a review of the current practices for the live donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Clinical practice. Autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Molecular advances in autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Autosomal Dominant Polycystic Kidney Disease Types 1 and 2: Assessment of US Sensitivity for Diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Unified criteria for ultrasonographic diagnosis of ADPKD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Screening a living kidney donor for polycystic kidney disease using heavily T2-weighted MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

A complete mutation screen of the ADPKD genes by DHPLC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Utilization and evaluation of living-related donors for patients with adult polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Molecular diagnostics for autosomal dominant polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

The renal lesions of Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Molecular genetics of Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Identification of mutations in the COL4A5 collagen gene in Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Genetic heterogeneity of Alport syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Ocular manifestations of autosomal recessive Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Women with Alport syndrome: risks and rewards of kidney donation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Renal transplantation in patients with Alport syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Clinical features of Fabry's disease in Australian patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Involvement of renal allograft by Fabry's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Atypical hemolytic-uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Hemolytic uremic syndrome recurrence after renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Complement Mutation-AssociatedDe NovoThrombotic Microangiopathy Following Kidney Transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Liver-kidney transplantation to cure atypical hemolytic uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Estimating prevalence in single-gene kidney diseases progressing to renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Primary hyperoxaluria type I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Transplantation for primary hyperoxaluria in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Preemptive liver transplantation from a living related donor for primary hyperoxaluria type I.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Clinical implications of mutation analysis in primary hyperoxaluria type 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Successful strategies for renal transplantation in primary oxalosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Treatment of primary hyperoxaluria type 1 with sequential liver and kidney transplants from the same living donor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Recurrent primary disease and de novo nephritis following renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Genetic forms of nephrotic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Recurrent Nephrotic Syndrome in Homozygous Truncating NPHS2 Mutation Is Not Due to Anti-Podocin Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

NPHS2 mutation associated with recurrence of proteinuria after transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.122

Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.

31 March 2020

1 reference

12 December 2020

NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele

1 reference

12 December 2020

Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria

1 reference

12 December 2020

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

1 reference

12 December 2020

COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis

1 reference

12 December 2020

Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome

1 reference

12 December 2020

Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome.

1 reference

12 December 2020

Primary hyperoxaluria type I.

1 reference

12 December 2020

High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.

1 reference

12 December 2020

AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria.

1 reference

12 December 2020

Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome

1 reference

12 December 2020

Recurrence of focal segmental sclerosis in children following renal transplantation

1 reference

12 December 2020

Alport syndrome and thin glomerular basement membrane disease

1 reference

12 December 2020

The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians

1 reference

12 December 2020

Transplantation in idiopathic nephrosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2010.122

1 reference

Dimensions Publication ID

26 July 2017

1030508968

0 references

1 reference